L
Louis F. Amorosa
Researcher at Rutgers University
Publications - 25
Citations - 1283
Louis F. Amorosa is an academic researcher from Rutgers University. The author has contributed to research in topics: Cyproheptadine & Phosphorylation. The author has an hindex of 11, co-authored 24 publications receiving 1124 citations. Previous affiliations of Louis F. Amorosa include Robert Wood Johnson University Hospital.
Papers
More filters
Journal ArticleDOI
An Update on Current Therapeutic Drugs Treating COVID-19.
Renyi Wu,Lujing Wang,Hsiao-Chen Dina Kuo,Ahmad Shannar,Rebecca Peter,Pochung Jordan Chou,Shanyi Li,Rasika Hudlikar,Xia Liu,Xia Liu,Zhigang Liu,George J. Poiani,George J. Poiani,Louis F. Amorosa,Luigi Brunetti,Luigi Brunetti,Ah-Ng Tony Kong +16 more
TL;DR: It is hoped that this review will provide useful and most updated therapeutic drugs to prevent, control, and treat COVID-19 patients until the approval of vaccines and specific drugs targeting SARS-CoV-2.
Journal ArticleDOI
Cyproheptadine-induced remission of Cushing's disease.
TL;DR: Experimental evidence suggests a Central-nervous-system origin of Cushing's disease and a role for serotonin in the regulation of ACTH release and the efficacy of cyproheptadine therapy.
Journal ArticleDOI
Ten-Year Experience with an Exercise-Based Outpatient Life-Style Modification Program in the Treatment of Diabetes Mellitus
TL;DR: A 10-yr experience with 255 patients enrolled in a comprehensive diabetes program that emphasized physical training suggests a program of regular aerobic training can be safely and effectively used in an outpatient population with diabetes mellitus for up to 3 mo.
Journal ArticleDOI
Fluvastatin with and without niacin for hypercholesterolemia
TL;DR: Although the fluvastatin-niacin combination in this study was without evidence of significant transaminitis, myopathy, or rhabdomyolysis, it would seem prudent to continue to monitor its safety with longer term use.
Journal ArticleDOI
Cyproheptadine-induced remission of cushingʼs disease
TL;DR: Experimental evidence suggests a central-nervous-system origin of Cushing's disease and a role for serotonin in the regulation of ACTH release and the efficacy of cyproheptadine therapy, therefore, was studied in three patients with such disease.